$4.15 -0.05 (-1.20%)

Nuvation Bio Inc. (NUVB)

Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for serious diseases, particularly in the fields of oncology and rare genetic disorders. The company is dedicated to discovering and advancing novel treatments that address unmet medical needs through targeted research and development efforts.

🚫 Nuvation Bio Inc. does not pay dividends

Company News

Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga • Avi Kapoor • April 3, 2024

U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday. Shares of Intel Corporation (NASDAQ: INTC) fell sharply in today’s pre-market trading after the company outlined a new financial framework for its foundry business. After the market close on Tuesday, Intel announced a new financial reporti...

INTCSHGMESOLIXPEVGUTS
Nuvation Bio Inc. (NUVB) Is Up 25.28% in One Week: What You Should Know
Zacks Investment Research • Zacks Equity Research • March 8, 2024

Does Nuvation Bio Inc. (NUVB) have what it takes to be a top stock pick for momentum investors? Let's find out.

Tracking David Abrams' Abrams Capital Management Portfolio - Q1 2023 Update
Seeking Alpha • John Vincent • May 25, 2023

David Abrams’ 13F portfolio value increased this quarter from $2.80B to $3.16B. Check out Abrams Capital Management holdings and trades for Q1 2023.

CTLPMETALADABGTDGGOOG